Pfizer Inc (PFE)-Financial and Strategic SWOT Analysis Review

Pfizer Inc (PFE)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH32190FSA
  • |
  • Pages: 104
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pfizer Inc (PFE)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pfizer Inc (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products in key therapeutic areas including internal medicine, cancer, vaccines, inflammation and immunology and rare diseases. It also provides sterile injectable pharmaceuticals, infusion systems, biosimilars, as well as active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells prescription pharmaceutical products through wholesalers, besides selling them directly to retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company provides its products in the US, Canada, Latin America, Asia, Japan, South Korea, New Zealand, Australia, Finland, Scandinavian countries, Africa, the Middle East and Turkey. Pfizer is headquartered in New York, the US.

Pfizer Inc Key Recent Developments

Mar 08, 2017: The Union for International Cancer Control and Pfizer Announce Next Phase of Global Grants Initiative Supporting Metastatic Breast Cancer Patients

Mar 06, 2017: Pfizer Selects Turner & Townsend For Expansion Of Its Clinical Research Unit In Belgium

Feb 23, 2017: Ronald E. Blaylock Elected to Pfizer's Board of Directors

Jan 31, 2017: Pfizer Reports Fourth-Quarter And Full-Year 2016 Results

Dec 20, 2016: Draper to Build Preclinical Microphysiological Systems with Pfizer to Help Predict Clinical Outcomes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Pfizer Inc-Key Facts 6

Pfizer Inc-Key Employees 7

Pfizer Inc-Key Employee Biographies 8

Pfizer Inc-Major Products and Services 9

Pfizer Inc-Pharmaceutical Pipeline Products Data 11

Pfizer Inc, Pipeline Products by Therapy Area 11

Pfizer Inc, Pipeline Products by Development Phase 12

Pfizer Inc-History 13

Pfizer Inc-Company Statement 40

Pfizer Inc-Locations And Subsidiaries 41

Head Office 41

Other Locations & Subsidiaries 41

Joint Venture 67

Section 2-Company Analysis 68

Pfizer Inc-Business Description 68

Pfizer Inc-Corporate Strategy 70

Pfizer Inc-SWOT Analysis 71

SWOT Analysis-Overview 71

Pfizer Inc-Strengths 71

Pfizer Inc-Weaknesses 72

Pfizer Inc-Opportunities 73

Pfizer Inc-Threats 74

Pfizer Inc-Key Competitors 75

Section 3-Company Financial Ratios 76

Financial Ratios-Capital Market Ratios 76

Financial Ratios-Annual Ratios 77

Performance Chart 79

Financial Performance 79

Financial Ratios-Interim Ratios 80

Financial Ratios-Ratio Charts 81

Section 4-Company's Lifesciences Financial Deals and Alliances 82

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 82

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 83

Pfizer Inc, Recent Deals Summary 84

Section 5-Company's Recent Developments 85

Mar 08, 2017: The Union for International Cancer Control and Pfizer Announce Next Phase of Global Grants Initiative Supporting Metastatic Breast Cancer Patients 85

Mar 06, 2017: Pfizer Selects Turner & Townsend For Expansion Of Its Clinical Research Unit In Belgium 86

Feb 23, 2017: Ronald E. Blaylock Elected to Pfizer's Board of Directors 87

Jan 31, 2017: Pfizer Reports Fourth-Quarter And Full-Year 2016 Results 88

Dec 20, 2016: Draper to Build Preclinical Microphysiological Systems with Pfizer to Help Predict Clinical Outcomes 93

Dec 12, 2016: Pioneers in Oncolytic Virus and Gene Therapy Fields Announce Formation of IGNITE Immunotherapy a Company Focused on Oncolytic Cancer Vaccine Discovery and Development 94

Dec 06, 2016: Pfizer Announces Expansion of ASPIRE Awards Program for 2017 to Include $5.5M in Funding for Breast and Hematologic Cancers 96

Dec 01, 2016: IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery 97

Nov 21, 2016: Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire 98

Nov 11, 2016: Pfizer Announces Major Expansion of Humanitarian Assistance Program 99

Section 6-Appendix 100

Methodology 100

Ratio Definitions 100

About GlobalData 104

Contact Us 104

Disclaimer 104

List of Figures

Pfizer Inc, Pipeline Products by Therapy Area 11

Pfizer Inc, Pipeline Products by Development Phase 12

Pfizer Inc, Performance Chart (2012-2016) 79

Pfizer Inc, Ratio Charts 81

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 82

Pfizer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 83

List of Tables

Pfizer Inc, Key Facts 6

Pfizer Inc, Key Employees 7

Pfizer Inc, Key Employee Biographies 8

Pfizer Inc, Major Products and Services 9

Pfizer Inc, Number of Pipeline Products by Therapy Area 11

Pfizer Inc, Number of Pipeline Products by Development Stage 12

Pfizer Inc, History 13

Pfizer Inc, Subsidiaries 41

Pfizer Inc, Joint Venture 67

Pfizer Inc, Key Competitors 75

Pfizer Inc, Ratios based on current share price 76

Pfizer Inc, Annual Ratios 77

Pfizer Inc (Cont...1), Annual Ratios 78

Pfizer Inc, Interim Ratios 80

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 82

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 83

Pfizer Inc, Recent Deals Summary 84

Currency Codes 100

Capital Market Ratios 100

Equity Ratios 101

Profitability Ratios 101

Cost Ratios 102

Liquidity Ratios 102

Leverage Ratios 102

Efficiency Ratios 103

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sanofi, Novartis AG, Merck & Co Inc, Johnson & Johnson, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca Plc, Amgen Inc, AbbVie Inc

Pfizer Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8118
Site License
USD 250 INR 16235
Corporate User License
USD 375 INR 24353

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com